Prosecution Insights
Last updated: April 19, 2026

Examiner: MOREAU, NASHARA LOUISE

Tech Center 1600 • Art Units: 1611 1628 1655

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
24
Total Applications
Interview Lift
784
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

12.5%
§101 Eligibility
15.6%
§102 Novelty
43.8%
§103 Obviousness
27.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18443597 METHOD AND COMPOSITION FOR IMPROVING THE APPEARANCE OF SKIN Non-Final OA The Procter & Gamble Company
17865953 COMPOSITIONS FOR CONTROLLING ARTHROPODS Non-Final OA The Procter & Gamble Company
18435415 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING PONCIRI FRUCTUS EXTRACT Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
18540186 Composition for the prevention, improvement or treatment of allergic diseases comprising an extract of Cassia mimosoides L. as an active ingredient Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
18515599 COMPOSITION FOR ANTI-OBESITY COMPRISING GREEN TEA PEPTIDE COMPOSITION Final Rejection AMOREPACIFIC CORPORATION
18012533 MYCELIAL CULTURE OF Irpex lacteus AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION AND TREATMENT OF DIABETES MEILLITUS Non-Final OA Jianmin LI
18685863 AGENT FOR PREVENTION AND/OR TREATMENT OF PORPHYROMONAS GINGIVALIS INFECTION Non-Final OA NUTRI CO., LTD.
18684682 COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY Non-Final OA THE AKKERMANSIA COMPANY
18294264 ACTIVE INGREDIENT COMPRISING OLIGO-GLUCANS DERIVED FROM THE CYTOSOLIC FRACTION OF SACCHAROMYCES CEREVISIAE, AND COSMETIC USES THEREOF Non-Final OA SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
18424754 MEDICINE FOR TOPICAL WOUND TREATMENT Non-Final OA kesaisi (Hainan) Technology Co., Ltd.
18417113 METHOD FOR IMPROVING COGNITIVE FUNCTION AND A DIETARY SUPPLEMENT FOR USE IN THE METHOD Non-Final OA RB Health (US) LLC
18575018 USE OF CISTANCHE TUBULOSA EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR RELIEVING DRY EYE SYNDROME Non-Final OA SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD. (HANGZHOU)
18519093 ONION EXTRACT, THE PREPARATION THEREOF AND THE USE FOR PROMOTING HAIR GROWTH THEREOF Non-Final OA FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION
18563001 BACTERIAL CELL WALL BOUND TO A MUCOPOLYSACCHARIDE, USES THEREOF AND PROCESS FOR ITS PRODUCTION Non-Final OA AILEENS PHARMA S.R.L.
18032023 A Purified Extract Isolated from Agrimonia Coreana Nakai Containing Abundant Amount of Active Ingredient, the Preparation Thereof, the Composition Comprising the Same as an Active Ingredient for Preventing or Treating Inflammation, Allergy and Atopic Dermatitis and the Use Thereof Non-Final OA Yuran NAM
18005721 ANTI-HYPERCHOLESTEROLEMIA COMPOSITION AND A METHOD OF MANUFACTURING THE SAME Non-Final OA NBI BIOSCIENCES PRIVATE LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month